159 related articles for article (PubMed ID: 8170168)
1. Major and minor breakpoint sites of chromosomal translocation t(14;18) in subtypes of non-Hodgkin's lymphomas.
Klefstrom J; Franssila K; Peltomäki P; Kaartinen M; Solin ML; Knuutila S
Leuk Res; 1994 Apr; 18(4):245-50. PubMed ID: 8170168
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
[TBL] [Abstract][Full Text] [Related]
3. Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas.
Ngan BY; Nourse J; Cleary ML
Blood; 1989 May; 73(7):1759-62. PubMed ID: 2713505
[TBL] [Abstract][Full Text] [Related]
4. Refinement of the BCL2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets.
Akasaka T; Akasaka H; Yonetani N; Ohno H; Yamabe H; Fukuhara S; Okuma M
Genes Chromosomes Cancer; 1998 Jan; 21(1):17-29. PubMed ID: 9443038
[TBL] [Abstract][Full Text] [Related]
5. Rearrangement of bcl-2 is detectable in Hodgkin's disease by polymerase chain reaction.
Mitani S; Oka T; Aoki N; Hojo I; Ota U; Mori S
Jpn J Cancer Res; 1994 Dec; 85(12):1229-32. PubMed ID: 7852186
[TBL] [Abstract][Full Text] [Related]
6. Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies.
Whang-Peng J; Knutsen T; Jaffe ES; Steinberg SM; Raffeld M; Zhao WP; Duffey P; Condron K; Yano T; Longo DL
Blood; 1995 Jan; 85(1):203-16. PubMed ID: 7803794
[TBL] [Abstract][Full Text] [Related]
7. The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction.
Athan E; Chadburn A; Knowles DM
Am J Pathol; 1992 Jul; 141(1):193-201. PubMed ID: 1632463
[TBL] [Abstract][Full Text] [Related]
8. Absence of t(14;18) major and minor breakpoints and of Bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease.
Louie DC; Kant JA; Brooks JJ; Reed JC
Am J Pathol; 1991 Dec; 139(6):1231-7. PubMed ID: 1750500
[TBL] [Abstract][Full Text] [Related]
9. t(2;18) and t(18;22) variant chromosomal translocations and bcl-2 gene rearrangements in human malignant lymphomas.
Larsen CJ; Mecucci C; Leroux D
Nouv Rev Fr Hematol (1978); 1990; 32(6):401-3. PubMed ID: 2129304
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
[TBL] [Abstract][Full Text] [Related]
11. Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma.
Child FJ; Russell-Jones R; Woolford AJ; Calonje E; Photiou A; Orchard G; Whittaker SJ
Br J Dermatol; 2001 Apr; 144(4):735-44. PubMed ID: 11298531
[TBL] [Abstract][Full Text] [Related]
12. Detection of rearrangements of the BCL2 major breakpoint region in follicular lymphomas. Correlation of polymerase chain reaction results with Southern blot analysis.
Ladanyi M; Wang S
Diagn Mol Pathol; 1992 Mar; 1(1):31-5. PubMed ID: 1342952
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.
Weiss LM; Warnke RA; Sklar J; Cleary ML
N Engl J Med; 1987 Nov; 317(19):1185-9. PubMed ID: 3657890
[TBL] [Abstract][Full Text] [Related]
14. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
Lee JT; Innes DJ; Williams ME
J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
[TBL] [Abstract][Full Text] [Related]
15. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
Butler MP; Iida S; Capello D; Rossi D; Rao PH; Nallasivam P; Louie DC; Chaganti S; Au T; Gascoyne RD; Gaidano G; Chaganti RS; Dalla-Favera R
Cancer Res; 2002 Jul; 62(14):4089-94. PubMed ID: 12124346
[TBL] [Abstract][Full Text] [Related]
16. Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing.
Kneba M; Eick S; Herbst H; Willigeroth S; Pott C; Bolz I; Bergholz M; Neumann C; Stein H; Krieger G
Cancer Res; 1991 Jun; 51(12):3243-50. PubMed ID: 2039999
[TBL] [Abstract][Full Text] [Related]
17. Structural alterations in the 5' region of the BCL2 gene in follicular lymphomas with BCL2-MBR or BCL2-MCR rearrangements.
Mikraki V; Ladanyi M; Chaganti RS
Genes Chromosomes Cancer; 1991 Mar; 3(2):117-21. PubMed ID: 1906343
[TBL] [Abstract][Full Text] [Related]
18. Cytometric detection of DNA amplified with fluorescent primers: applications to analysis of clonal bcl-2 and IgH gene rearrangements in malignant lymphomas.
Barker RL; Worth CA; Peiper SC
Blood; 1994 Feb; 83(4):1079-85. PubMed ID: 8111048
[TBL] [Abstract][Full Text] [Related]
19. Rearrangement of bcl-2 genes in malignant lymphomas in Chinese patients.
Chen PM; Lin SH; Seto M; Chao SC; Chiou TJ; Hsieh RK; Lin CZ; Fan S; Tzeng CH; Ueda R
Cancer; 1993 Dec; 72(12):3701-6. PubMed ID: 8252486
[TBL] [Abstract][Full Text] [Related]
20. Incidence of BCL-2 gene rearrangements in Argentinean non-Hodgkin lymphoma patients: increased frequency of breakpoints outside of MBR and MCR.
Noriega MF; De Brasi C; Narbaitz M; Slavutsky I
Blood Cells Mol Dis; 2004; 32(1):232-9. PubMed ID: 14757440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
